Literature DB >> 6421681

Characterization of the effect of plasma lipoproteins on platelet function in vitro.

M Aviram, J G Brook.   

Abstract

Thrombin-induced platelet activation is enhanced by very low and low density lipoproteins but decreased by high density lipoprotein. Plasma lipoproteins maximally affect platelet aggregation and 14C-serotonin release in a gel-filtered platelet preparation within 10 min of incubation at 37 degrees C. This effect is saturable and physiologic concentrations of lipoproteins are required in order to attain this saturation. When no aggregating agent is added to the incubation medium, the lipoproteins alone did not alter platelet aggregation. However, 14C-serotonin release is increased by very-low- and low-density lipoproteins alone more than by high density lipoprotein. On removal of the lipoproteins after incubation with the platelets, and subsequent testing of platelet function, minimal influence of these lipoproteins on the platelet function remains. Arachidonic acid causes similar results to thrombin when added to the platelet suspension after incubation with the lipoprotein. Our results further emphasize the 'opposing effects' of very low and low density lipoproteins as compared to high density lipoproteins on platelets and/or platelet-thrombin interaction.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6421681     DOI: 10.1159/000214820

Source DB:  PubMed          Journal:  Haemostasis        ISSN: 0301-0147


  6 in total

Review 1.  Low high-density lipoprotein cholesterol: physiological background, clinical importance and drug treatment.

Authors:  Martin Hersberger; Arnold von Eckardstein
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 2.  Platelet activation in normo- and hyperlipoproteinemias.

Authors:  J Nimpf; H Wurm; G M Kostner; T Kenner
Journal:  Basic Res Cardiol       Date:  1986 Sep-Oct       Impact factor: 17.165

3.  Native and modified low-density-lipoprotein interaction with human platelets in normal and homozygous familial-hypercholesterolaemic subjects.

Authors:  A Shmulewitz; J G Brook; M Aviram
Journal:  Biochem J       Date:  1984-11-15       Impact factor: 3.857

4.  Chylomicron-like particles in severe hypertriglyceridemia.

Authors:  M Aviram; Y Sechter; J G Brook
Journal:  Lipids       Date:  1985-04       Impact factor: 1.880

5.  Differential effect of platelet inhibitors in normal and in hypercholesterolaemic subjects.

Authors:  M Aviram; G Winterstein; J G Brook
Journal:  Br J Clin Pharmacol       Date:  1985-06       Impact factor: 4.335

Review 6.  Triglyceride-Rich Lipoproteins and Their Remnants as Silent Promoters of Atherosclerotic Cardiovascular Disease and Other Metabolic Disorders: A Review.

Authors:  Radu Sascău; Alexandra Clement; Rodica Radu; Cristina Prisacariu; Cristian Stătescu
Journal:  Nutrients       Date:  2021-05-22       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.